Cargando…
Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine
We present case reports of two patients treated with miltefosine for mucocutaneous leishmaniasis whose gastrointestinal symptoms were initially diagnosed as a drug reaction and only later recognized as due to COVID-19. Gastrointestinal symptoms of COVID-19 are unusual, whereas gastrointestinal adver...
Autores principales: | Soto, Jaime A., Méndez, María Isabel, Berman, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103461/ https://www.ncbi.nlm.nih.gov/pubmed/33705346 http://dx.doi.org/10.4269/ajtmh.20-1510 |
Ejemplares similares
-
No evidence for cardiotoxicity of miltefosine()
por: Dorlo, Thomas P.C.
Publicado: (2022) -
MDR1 causes resistance to the antitumour drug miltefosine
por: Rybczynska, M, et al.
Publicado: (2001) -
Case Report: Pulmonary Leptospirosis Misdiagnosed as COVID-19
por: Turmel, Jean-Marie, et al.
Publicado: (2022) -
Integral Role of Water in the Solid-State Behavior
of the Antileishmanial Drug Miltefosine
por: Hall, Amy V., et al.
Publicado: (2022) -
Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas
por: Alli, Ammar, et al.
Publicado: (2021)